We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

125 hedge funds and large institutions have $978M invested in Arena Pharmaceuticals Inc in 2017 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more call options, than puts

Call options by funds: $47.9M | Put options by funds: $16.6M

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

34% more capital invested

Capital invested by funds: $731M → $978M (+$247M)

32% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 19

13% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 40

5% more funds holding

Funds holding: 119 → 125 (+6)

Holders
125
Holders Change
+6
Holders Change %
+5.04%
% of All Funds
2.84%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
25
Increased
45
Reduced
40
Closed
19
Calls
$47.9M
Puts
$16.6M
Net Calls
+$31.3M
Net Calls Change
+$13.6M

Top Buyers

1
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$15.3M
2
DM
Deerfield Management
New York
+$12.8M
3
CS
Credit Suisse
Switzerland
+$7.98M
4
Citadel Advisors
Citadel Advisors
Florida
+$7.45M
5
Invesco
Invesco
Georgia
+$6.3M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$9.39M
2
BIM
Bogle Investment Management
Massachusetts
-$8.96M
3
State Street
State Street
Massachusetts
-$8.76M
4
NI
Numeric Investors
Massachusetts
-$7.03M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
101
Advisor Group
Arizona
$79K -$1.57K -55 -2%
Zurich Cantonal Bank
102
Zurich Cantonal Bank
Switzerland
$73K +$36.3K +1,273 +144%
Public Employees Retirement Association of Colorado
103
Public Employees Retirement Association of Colorado
Colorado
$54K +$45.2K +1,586 New
Pacer Advisors
104
Pacer Advisors
Pennsylvania
$53K +$44.2K +1,550 New
QT
105
Quantbot Technologies
New York
$45K +$15.6K +546 +68%
LTFS
106
Ladenburg Thalmann Financial Services
Florida
$21K – – –
EDRH
107
Edmond de Rothschild Holding
Switzerland
$20K – – –
AAM
108
Advisors Asset Management
Colorado
$18K +$14.8K +518 New
FCB
109
First Command Bank
Texas
$17K -$22.8K -800 -62%
FCFS
110
First Command Financial Services
Texas
$17K -$22.8K -800 -62%
RFA
111
Reilly Financial Advisors
California
$17K – – –
US Bancorp
112
US Bancorp
Minnesota
$15K -$16.3K -571 -57%
MAM
113
Meeder Asset Management
Ohio
$15K +$3.56K +125 +38%
PMFA
114
Plante Moran Financial Advisors
Michigan
$14K +$2.42K +85 +27%
APA
115
American Portfolios Advisors
New York
$12.6K +$10.5K +370 New
RWA
116
Ropes Wealth Advisors
Massachusetts
$9K – – –
CHP
117
Cable Hill Partners
Oregon
$8K – – –
Bank of Montreal
118
Bank of Montreal
Ontario, Canada
$7K -$336K -11,800 -98%
MA
119
MUFG Americas
New York
$6K -$3.08K -108 -38%
GWM
120
Geneos Wealth Management
Colorado
$3K -$663K -23,278 -100%
WEC
121
Winslow Evans & Crocker
Massachusetts
$2.38K – – –
IA
122
IFP Advisors
Florida
$1K -$2.99K -105 -75%
SPIA
123
Steward Partners Investment Advisory
New York
$1K – – –
TFS
124
TrustCore Financial Services
Tennessee
$1K +$855 +30 New
BIM
125
Bogle Investment Management
Massachusetts
– -$8.96M -351,579 Closed
2 3 4
5
6

ARNA Hedge Fund Activity: Q4 2017 in Review

125 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q4 2017, worth a combined $978M — up 34% from $731M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ARNA positions and 19 closed out — a net gain of 6 holders — while 45 added to existing stakes and 40 trimmed.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $15.3M. The largest seller was Renaissance Technologies, cutting an estimated $9.39M.

  • 125 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q4 2017, up from 119 in Q3 2017.
  • Funds reported $978M of Arena Pharmaceuticals Inc stock for Q4 2017, up 34% quarter-over-quarter.
  • 25 funds opened new Arena Pharmaceuticals Inc positions in Q4 2017 and 19 closed out, a net change of +6 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q4 2017 was Alyeska Investment Group, an estimated $15.3M added.
  • The largest Arena Pharmaceuticals Inc seller in Q4 2017 was Renaissance Technologies, an estimated $9.39M sold.

Based on aggregated 13F filings for Q4 2017.